SEC Form D private-offering filing

Myrtelle Inc.

Name: Myrtelle Inc. - new SEC Form D private-offering filing, New York, NY
Published: 2025-12-23

A new SEC Form D private-offering notice from New York, NY, a $55,162,634 filer-stated offering target in Biotech. The source filing is one click away.

Myrtelle Inc. site↗ Verified via SEC Form D

Gene therapy company developing treatments for Canavan disease and other myelin based neurological disorders, partnered with Pfizer

Filed 2025-12-23Filed to raise $55,162,634First money in 2025-12-11Raised so far $30,531,749HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified myrtellegtx.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.